MetLife Inc stock (US59156R1086): Keefe Bruyette upgrades to Outperform

Keefe, Bruyette & Woods upgraded MetLife Inc (MET) to Outperform on May 13, 2026, raising the price target to $98 from $87. The stock traded at 72.50 USD on NYSE as of May 12.

MetLife Inc, a leading US insurer, received an upgrade from Keefe, Bruyette & Woods analyst Ryan Krueger, who maintained an 'Outperform' rating while lifting the price target to $98.00 from $87.00 on May 13, 2026, GuruFocus as of 05/13/2026. This reflects confidence in the company's fundamentals amid a strong US insurance market. The stock closed at approximately 72.50 USD on May 12, 2026, on NYSE, ad-hoc-news.de as of 05/12/2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: MetLife Inc
• Sector/industry: Insurance and employee benefits
• Headquarters/country: United States
• Core markets: US, global
• Key revenue drivers: Life insurance, annuities, asset management
• Home exchange/listing venue: NYSE (MET)
• Trading currency: USD

MetLife Inc: core business model

MetLife Inc operates as a diversified financial services company focused primarily on insurance and employee benefits. The business centers on providing life insurance, annuities, group benefits, and retirement solutions to individuals and corporations worldwide, with a strong US presence, ad-hoc-news.de as of 05/12/2026. Founded in 1868, it serves millions through a mix of direct sales and partnerships.

The company generates revenue from premiums, investment income, and fees. Its US segment, a key driver for American investors, benefits from market leadership in group life and dental insurance.

Main revenue and product drivers for MetLife Inc

MetLife's primary revenues stem from its US business (over 50% of premiums), Asia, Latin America, and Europe. Key products include term life, whole life policies, annuities for retirement planning, and employee benefits like disability coverage. Asset management via MetLife Investment Management adds diversified income streams.

For US investors, MetLife's exposure to the domestic economy and stable insurance demand provides resilience. The NYSE-listed stock (MET) offers liquidity and dividend potential typical of blue-chip insurers.

Industry trends and competitive position

The US insurance sector faces digital transformation, consolidation, and rising interest rates boosting investment yields. MetLife holds a top position by assets, competing with Prudential and Northwestern Mutual, while expanding digitally for younger customers.

Why MetLife Inc matters for US investors

Listed on NYSE, MetLife provides US retail investors access to a global insurer with heavy domestic weighting. Its scale supports steady dividends and exposure to economic recovery cycles, relevant for long-term portfolios tracking S&P 500 insurers.

Conclusion

MetLife Inc continues to demonstrate strength in core insurance operations, bolstered by the recent analyst upgrade from Keefe, Bruyette & Woods. With a solid US market position and global diversification, the company navigates industry shifts effectively. Investors track its performance amid evolving economic conditions.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.